The economic impact of the problem is evident ... And there is still time; for example, the patent loss for Ozempic is expected in 2031. Later for new generations, like Mounjaro or Wegoby.

Many folks in NC can’t access Ozempic due to limited insurance coverage. But policy changes and falling prices may expand ...

Research even suggests it can change users' sense of smell, and other common side effects include diarrhoea, nausea, 'sulphur ...

An international study reveals that the drug can reverse liver damage in patients. An international study led by researchers ...

Ozempic is inspiring a new entry in dupe culture. FDA approval may still be a few years away, but Wall Street and obesity experts are excited nonetheless and predict that the impacts could be ...

Importing foreign price controls via President Trump’s MFN scheme is not the answer. They risk patients access and discourages needed innovation.

The economic uncertainty created by President ... Geography is a major player in potential tariffs on GLP-1 drugs like Ozempic and Wegovy, as well. Novo Nordisk, the makers of the increasingly ...

Danish drugmaker Novo Nordisk, known for its blockbuster diabetes and weight-loss treatments Ozempic and Wegovy, said Friday its chief executive was stepping down in the wake of "market challenges".

Denmark’s economic growth, which was driven by what economists described as an “exceptional surge” in pharmaceutical exports, ...

In signing an executive order aimed at reducing U.S. drug prices, President Donald Trump said some prices would be cut in ...